ArticleActa parasitologica2026
Characterization and Evaluation of Justicia adhatoda L. and Its Green Synthesized Nanoparticles for Its Efficacy in Culex quinquefasciatus.
Article in Acta parasitologica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundJusticia adhatoda L., commonly referred to as Vasa or Vasaka, is a significant therapeutic shrub in traditional ayurvedic practice. This study examines the therapeutic potential of leaves from J. adhatoda in treating Mosquito-borne diseases. We hypothesized that J. adhatoda extract and its green synthesized silver nanoparticles may have antibacterial and antilarvicidal effects.
methodsThe aqueous leaf extracts of J. adhatoda were employed as a reducing and capping agent for the AgNP synthesis. The synthesized AgNPs were confirmed using Scanning Electron Microscopy (SEM), Dynamic Light Scattering (DLS), UV-Visible Absorbance Spectroscopy, Fourier Transform Infrared Spectroscopy (FT-IR). The analysis of plant-derived compounds in the leaf extracts using methanol, ethanol, chloroform and water showed the existence of alkaloids, terpenoids, phenols, tannins and glycosides. The leaf extracts of J. adhatoda and their silver nanoparticles demonstrated significant antibacterial efficacy against S. epidermidis, a bacterium known to cause secondary infections, in the case of Lymphatic Filariasis, antioxidant activity was assessed to characterize the leaf's phytochemical profile and larvicidal efficacy was evaluated against Cx. quinquefasciatus.
resultsPhytochemical analysis showed the presence of alkaloids, terpenoids, phenols, tannins, and glycosides across the solvents. Both the leaf extract and its AgNPs showed significant antibacterial efficacy against S.epidermidis and acted as a good Radical Scavenging agent. The synthesized silver nanoparticles exhibited a better larvicidal effect [LC
conclusionsThe findings highlight the potential of J. adhatoda and its green-synthesised AgNPs as an eco-friendly and promising therapeutic agent in the control and management of larvicidal activity against Cx. quinquefasciatus and antibacterial efficacy against S. epidermidis. More comprehensive studies will be carried out to analyze the efficacy of J. adhatoda and its nanomaterial by evaluating the larvicidal and antibacterial activity by conducting in vitro analysis.
Indexed as
Identifiers
42541650What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.